Lunai Bioworks (RENB) Insider Trading & Ownership $1.54 +0.28 (+21.72%) Closing price 09/30/2025Extended Trading$1.54 0.00 (0.00%) As of 09/30/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lunai Bioworks (NASDAQ:RENB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.50%Number OfInsiders Buying(Last 3 Years)0Number OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$480.55K Get RENB Insider Trade Alerts Want to know when executives and insiders are buying or selling Lunai Bioworks stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RENB Insider Buying and Selling by Quarter Lunai Bioworks Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/29/2024Anderson Wittekind WilliamMajor ShareholderSell111$13.00$1,443.00 7/17/2024Anderson Wittekind WilliamMajor ShareholderSell1,636$14.60$23,885.60 7/15/2024Anderson Wittekind WilliamMajor ShareholderSell2,195$14.10$30,949.50 7/11/2024Anderson Wittekind WilliamMajor ShareholderSell1,489$15.10$22,483.90 7/9/2024Anderson Wittekind WilliamMajor ShareholderSell463$15.30$7,083.90 7/5/2024Anderson Wittekind WilliamMajor ShareholderSell6,000$15.50$93,000.00 7/3/2024Anderson Wittekind WilliamMajor ShareholderSell5,000$15.10$75,500.00 7/1/2024Anderson Wittekind WilliamMajor ShareholderSell6,000$15.60$93,600.00 6/27/2024Anderson Wittekind WilliamMajor ShareholderSell1,467$15.00$22,005.00 6/25/2024Anderson Wittekind WilliamMajor ShareholderSell2,000$15.80$31,600.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/14/2024Anderson Wittekind WilliamMajor ShareholderSell5,000$15.80$79,000.00 (Data available from 1/1/2013 forward) RENB Insider Trading Activity - Frequently Asked Questions Who is on Lunai Bioworks' Insider Roster? The list of insiders at Lunai Bioworks includes Anderson Wittekind William. Learn more on insiders at RENB. What percentage of Lunai Bioworks stock is owned by insiders? 0.50% of Lunai Bioworks stock is owned by insiders. Learn more on RENB's insider holdings. Which Lunai Bioworks insiders have been selling company stock? The following insider sold RENB shares in the last 24 months: Anderson Wittekind William ($480,550.90). How much insider selling is happening at Lunai Bioworks? Insiders have sold a total of 31,361 Lunai Bioworks shares in the last 24 months for a total of $480,550.90 sold. Lunai Bioworks Key ExecutivesHon. Mark R. Dybul M.D. (Age 61)CEO, Director & Member of HBV Scientific Advisory Board Compensation: $764.58kDr. Francois Binette M.Sc. (Age 60)Ph.D., COO and Executive VP for Research & Development Compensation: $504.38kDr. Serhat GümrükcüCo-Founder & InventorMr. Simon Tarsh (Age 63)Interim Chief Financial Officer Mr. Greg Duczynski Ph.D.Senior Vice President for Clinical Operations More Insider Trading Tools from MarketBeat Related Companies Bicara Therapeutics Insider Trades Spyre Therapeutics Insider Trades Upstream Bio Insider Trades Sana Biotechnology Insider Trades Relay Therapeutics Insider Trades Precigen Insider Trades Rapport Therapeutics Insider Trades Septerna Insider Trades Mind Medicine (MindMed) Insider Trades Ginkgo Bioworks Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Marvell Insiders Buy Shares—Should Investors Follow Suit?This Insider Just Made a Massive Bet on Transocean's ComebackInsider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t WorryTop Insider Buys and Sells From September: Buy, Sell, or Hold? This page (NASDAQ:RENB) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lunai Bioworks Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lunai Bioworks With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
